About this trial
This randomized controlled trial aims to evaluate the effect of a structured patient-centered educational program on postoperative outcomes among patients undergoing hip fracture surgery. Participants will be randomly assigned to either an intervention group receiving the educational program in addition to routine care or a control group receiving routine care only. The study will assess whether the educational program improves postoperative recovery, functional independence, and pain outcomes following hip fracture surgery.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients undergoing hip fracture surgery.
Medically stable and able to participate in the educational program.
Able to understand study instructions and provide written informed consent.
Disqualifiers
Cognitive impairment that prevents participation (e.g., dementia).
Severe comorbidities that significantly limit mobility.
Discharged before completion of the educational program.
Trial design
Parallel
Treatments tested in this trial
Structured Patient-Centered Educational Program.
BehavioralA structured educational program focusing on postoperative care, pain management, rehabilitation exercises, safe mobility, prevention of complications, and activities of daily living, supported by an illustrated educational booklet.
Treatment groups
Trial outcomes
Primary outcomes
Functional Independence Measure (FIM) Total Score.
The Functional Independence Measure (FIM) will be used to assess functional independence following hip fracture surgery. The FIM consists of 18 items with a total score ranging from 18 to 126. Higher scores indicate greater functional independence and better postoperative functional outcomes.
Secondary outcomes
Visual Analog Scale (VAS) Pain Score.
Pain intensity will be assessed using the Visual Analog Scale (VAS). The VAS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.